Correlation Engine 2.0
Clear Search sequence regions

  • antibodies (2)
  • humans (1)
  • patients (1)
  • tocilizumab (4)
  • Sizes of these terms reflect their relevance to your search.

    Based on mounting evidence that tocilizumab improves survival in critically ill patients with COVID-19, the FDA granted it an emergency use authorization for COVID-19 treatment in June. Two months later, the agency added tocilizumab to its list of drug shortages, where it remains despite a slowly increasing supply. ©2021 American Association for Cancer Research.


    COVID-19 Use Causes Tocilizumab Shortage. Cancer discovery. 2021 Dec 01;11(12):2950

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34615654

    View Full Text